CD44 and breast carcinoma: CD49f and CD44, a stem cell marker, are transcriptionally upregulated by Y-box binding protein-1 (YB-1) in breast cancer cells, enhancing the stem-like properties of these cells, which include self-renewal, colony forming efficiency and drug resistance [104].